Gilde Healthcare
Gilde Healthcare Acquires Majority Stake in Danish Drug Development Consultancy KLIFO to Support International Growth Ambitions
Gilde Healthcare Acquires Majority Stake in Danish Drug Development Consultancy KLIFO to Support International Growth Ambitions
Northern European integrated drug development consultancy aims to further expand service offering and geographical footprint
UTRECHT, the Netherlands and COPENHAGEN, Denmark, May 06, 2021 (GLOBE NEWSWIRE) Gilde Healthcare, a specialized healthcare investor, and KLIFO A/S, a leading Northern European drug development consultancy with significant experience in partnering with biotech and pharmaceutical companies to advance their drug development projects, today announce that Gilde Healthcare’s Private Equity fund has acquired a majority stake in KLIFO. Gilde Healthcare aims to support KLIFO’s growth in the dynamically developing pharma outsourcing sector.
Northern European integrated drug development consultancy aims to further expand service offering and geographical footprintUTRECHT, the Netherlands and COPENHAGEN, Denmark, May 06, 2021 (GLOBE NEWSWIRE)
Biotechnology Statistics - Sweden
Collection/compilation type: R&D survey.
Variables:
R&D expenditure (Government and Higher Education)
Scope: Business enterprise sector, government sector, higher education sector.
Frequency: Biennial.
Classification used: N/A
Definition used: No explicit definition is given in the national R&D survey; however, the OECD definition will be incorporated in future surveys.
Output:
Research and Experimental Development in the Higher Education Sector 2001 (in Swedish)
Research and Experimental Development in the General Government Sector 2001 (in Swedish).
Contact comments: Data are available for 1997, 1999 and 2001.
Future plans (plans for new collections, strategies, experiences etc.): N/A
Collection/compilation type: Analysis of innovation system
Se Incendia una Bodega en la Colonia Miravalle pagina24.com.mx - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pagina24.com.mx Daily Mail and Mail on Sunday newspapers.
Visiopharm, a leader in AI-based digital pathology, has begun its partnership with the Region of Southern Denmark, to supply the network of four hospitals with